Report cover image

Global Inhaler Devices for Respiratory Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 195 Pages
SKU # APRC20278250

Description

Summary

According to APO Research, The global Inhaler Devices for Respiratory Medicines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inhaler Devices for Respiratory Medicines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Inhaler Devices for Respiratory Medicines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Inhaler Devices for Respiratory Medicines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Inhaler Devices for Respiratory Medicines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Inhaler Devices for Respiratory Medicines include Novartis, Viatris, Mylan, AstraZeneca, Vectura, Teva Pharmaceutical Industries, PARI International, OMRON and Monaghan Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Inhaler Devices for Respiratory Medicines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Inhaler Devices for Respiratory Medicines, also provides the sales of main regions and countries. Of the upcoming market potential for Inhaler Devices for Respiratory Medicines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhaler Devices for Respiratory Medicines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Inhaler Devices for Respiratory Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Inhaler Devices for Respiratory Medicines sales, projected growth trends, production technology, application and end-user industry.

Inhaler Devices for Respiratory Medicines Segment by Company

Novartis
Viatris
Mylan
AstraZeneca
Vectura
Teva Pharmaceutical Industries
PARI International
OMRON
Monaghan Medical
Koninklijke Philips
H&T Presspart
GlaxoSmithKline (GSK)
Chiesi Farmaceutici
Boehringer Ingelheim
AptarGroup
Inhaler Devices for Respiratory Medicines Segment by Type

Metered- dose Inhalers
Dry-powder Inhalers
Nebulizers
Inhaler Devices for Respiratory Medicines Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)
Cystic Fibrosis (CF)
Idiopathic Pulmonary Fibrosis (IPF)
Asthma
Others
Inhaler Devices for Respiratory Medicines Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaler Devices for Respiratory Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhaler Devices for Respiratory Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaler Devices for Respiratory Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhaler Devices for Respiratory Medicines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhaler Devices for Respiratory Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inhaler Devices for Respiratory Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Inhaler Devices for Respiratory Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Inhaler Devices for Respiratory Medicines Market Size, 2020 VS 2024 VS 2031
1.3 Global Inhaler Devices for Respiratory Medicines Market Size Estimates and Forecasts (2020-2031)
1.4 Global Inhaler Devices for Respiratory Medicines Sales Estimates and Forecasts (2020-2031)
1.5 Global Inhaler Devices for Respiratory Medicines Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Inhaler Devices for Respiratory Medicines Market Dynamics
2.1 Inhaler Devices for Respiratory Medicines Industry Trends
2.2 Inhaler Devices for Respiratory Medicines Industry Drivers
2.3 Inhaler Devices for Respiratory Medicines Industry Opportunities and Challenges
2.4 Inhaler Devices for Respiratory Medicines Industry Restraints
3 Inhaler Devices for Respiratory Medicines Market by Manufacturers
3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Manufacturers (2020-2025)
3.2 Global Inhaler Devices for Respiratory Medicines Sales by Manufacturers (2020-2025)
3.3 Global Inhaler Devices for Respiratory Medicines Average Sales Price by Manufacturers (2020-2025)
3.4 Global Inhaler Devices for Respiratory Medicines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Inhaler Devices for Respiratory Medicines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Inhaler Devices for Respiratory Medicines Manufacturers, Product Type & Application
3.7 Global Inhaler Devices for Respiratory Medicines Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Inhaler Devices for Respiratory Medicines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Inhaler Devices for Respiratory Medicines Players Market Share by Revenue in 2024
3.8.3 2024 Inhaler Devices for Respiratory Medicines Tier 1, Tier 2, and Tier 3
4 Inhaler Devices for Respiratory Medicines Market by Type
4.1 Inhaler Devices for Respiratory Medicines Type Introduction
4.1.1 Metered- dose Inhalers
4.1.2 Dry-powder Inhalers
4.1.3 Nebulizers
4.2 Global Inhaler Devices for Respiratory Medicines Sales by Type
4.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Inhaler Devices for Respiratory Medicines Sales by Type (2020-2031)
4.2.3 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2020-2031)
4.3 Global Inhaler Devices for Respiratory Medicines Revenue by Type
4.3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2020-2031)
4.3.3 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2020-2031)
5 Inhaler Devices for Respiratory Medicines Market by Application
5.1 Inhaler Devices for Respiratory Medicines Application Introduction
5.1.1 Chronic Obstructive Pulmonary Disease (COPD)
5.1.2 Cystic Fibrosis (CF)
5.1.3 Idiopathic Pulmonary Fibrosis (IPF)
5.1.4 Asthma
5.1.5 Others
5.2 Global Inhaler Devices for Respiratory Medicines Sales by Application
5.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Inhaler Devices for Respiratory Medicines Sales by Application (2020-2031)
5.2.3 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2020-2031)
5.3 Global Inhaler Devices for Respiratory Medicines Revenue by Application
5.3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2020-2031)
5.3.3 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2020-2031)
6 Global Inhaler Devices for Respiratory Medicines Sales by Region
6.1 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Inhaler Devices for Respiratory Medicines Sales by Region (2020-2031)
6.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Region (2020-2025)
6.2.2 Global Inhaler Devices for Respiratory Medicines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Inhaler Devices for Respiratory Medicines Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Inhaler Devices for Respiratory Medicines Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Inhaler Devices for Respiratory Medicines Revenue by Region
7.1 Global Inhaler Devices for Respiratory Medicines Revenue by Region
7.1.1 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Inhaler Devices for Respiratory Medicines Revenue by Region (2020-2025)
7.1.3 Global Inhaler Devices for Respiratory Medicines Revenue by Region (2026-2031)
7.1.4 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Inhaler Devices for Respiratory Medicines Revenue (2020-2031)
7.2.2 North America Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Inhaler Devices for Respiratory Medicines Revenue (2020-2031)
7.3.2 Europe Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Inhaler Devices for Respiratory Medicines Revenue (2020-2031)
7.4.2 Asia-Pacific Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Novartis
8.1.1 Novartis Comapny Information
8.1.2 Novartis Business Overview
8.1.3 Novartis Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Novartis Inhaler Devices for Respiratory Medicines Product Portfolio
8.1.5 Novartis Recent Developments
8.2 Viatris
8.2.1 Viatris Comapny Information
8.2.2 Viatris Business Overview
8.2.3 Viatris Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Viatris Inhaler Devices for Respiratory Medicines Product Portfolio
8.2.5 Viatris Recent Developments
8.3 Mylan
8.3.1 Mylan Comapny Information
8.3.2 Mylan Business Overview
8.3.3 Mylan Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Mylan Inhaler Devices for Respiratory Medicines Product Portfolio
8.3.5 Mylan Recent Developments
8.4 AstraZeneca
8.4.1 AstraZeneca Comapny Information
8.4.2 AstraZeneca Business Overview
8.4.3 AstraZeneca Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio
8.4.5 AstraZeneca Recent Developments
8.5 Vectura
8.5.1 Vectura Comapny Information
8.5.2 Vectura Business Overview
8.5.3 Vectura Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Vectura Inhaler Devices for Respiratory Medicines Product Portfolio
8.5.5 Vectura Recent Developments
8.6 Teva Pharmaceutical Industries
8.6.1 Teva Pharmaceutical Industries Comapny Information
8.6.2 Teva Pharmaceutical Industries Business Overview
8.6.3 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio
8.6.5 Teva Pharmaceutical Industries Recent Developments
8.7 PARI International
8.7.1 PARI International Comapny Information
8.7.2 PARI International Business Overview
8.7.3 PARI International Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 PARI International Inhaler Devices for Respiratory Medicines Product Portfolio
8.7.5 PARI International Recent Developments
8.8 OMRON
8.8.1 OMRON Comapny Information
8.8.2 OMRON Business Overview
8.8.3 OMRON Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 OMRON Inhaler Devices for Respiratory Medicines Product Portfolio
8.8.5 OMRON Recent Developments
8.9 Monaghan Medical
8.9.1 Monaghan Medical Comapny Information
8.9.2 Monaghan Medical Business Overview
8.9.3 Monaghan Medical Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio
8.9.5 Monaghan Medical Recent Developments
8.10 Koninklijke Philips
8.10.1 Koninklijke Philips Comapny Information
8.10.2 Koninklijke Philips Business Overview
8.10.3 Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio
8.10.5 Koninklijke Philips Recent Developments
8.11 H&T Presspart
8.11.1 H&T Presspart Comapny Information
8.11.2 H&T Presspart Business Overview
8.11.3 H&T Presspart Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio
8.11.5 H&T Presspart Recent Developments
8.12 GlaxoSmithKline (GSK)
8.12.1 GlaxoSmithKline (GSK) Comapny Information
8.12.2 GlaxoSmithKline (GSK) Business Overview
8.12.3 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio
8.12.5 GlaxoSmithKline (GSK) Recent Developments
8.13 Chiesi Farmaceutici
8.13.1 Chiesi Farmaceutici Comapny Information
8.13.2 Chiesi Farmaceutici Business Overview
8.13.3 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio
8.13.5 Chiesi Farmaceutici Recent Developments
8.14 Boehringer Ingelheim
8.14.1 Boehringer Ingelheim Comapny Information
8.14.2 Boehringer Ingelheim Business Overview
8.14.3 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio
8.14.5 Boehringer Ingelheim Recent Developments
8.15 AptarGroup
8.15.1 AptarGroup Comapny Information
8.15.2 AptarGroup Business Overview
8.15.3 AptarGroup Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio
8.15.5 AptarGroup Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Inhaler Devices for Respiratory Medicines Value Chain Analysis
9.1.1 Inhaler Devices for Respiratory Medicines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Inhaler Devices for Respiratory Medicines Production Mode & Process
9.2 Inhaler Devices for Respiratory Medicines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Inhaler Devices for Respiratory Medicines Distributors
9.2.3 Inhaler Devices for Respiratory Medicines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.